Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
- Article
- Visual Overview
- Abstract
- I. Introduction
- II. Relevance of Janus Kinases for Tumorigenesis
- III. Histone Deacetylases Are Valid Pharmacological Targets in Janus Kinase Mutant Tumor Cells
- IV. Chemically Coupled Multitargeting Drugs
- V. Targeting Aberrant Janus Kinase Signaling by Proteolysis Targeting Chimeras and Histone Deacetylase Inhibitors
- VI. Clinical Trials to Assess the Safety and Efficacy of Combined Pharmacological Targeting of Janus Kinases and Histone Deacetylases
- VII. Summary
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement